 |
Recombinant fully human monoclonal antibody to anthrax protective antigen |
|---|---|
| Trade Name | Valortim |
| Orphan Indication | Anthrax |
| USA Market Approval | USA |
| USA Designation Date | 2006-02-16 00:00:00 |
| Sponsor | PharmAthene, Inc.;One Park Place, Suite 450;Annapolis, Maryland, 21401 |
